LIDOCAINE AGUETTANT 20 mg/ml INJECTABLE SOLUTION IN PRE-FILLED SYRINGE

2. What you need to know before you use Lidocaine Aguettant

Do not use Lidocaine Aguettant:

• if you are allergic to lidocaine, local anesthetics of the amide type, or any other component of this medicine (listed in section 6).

Warnings and precautions

• Talk to your doctor, pharmacist, or nurse before you are given Lidocaine Aguettant:
• if you have epilepsy. Your doctor will closely monitor any symptoms.
• if you have kidney or liver disease.
• if you have a disease that causes muscle weakness (myasthenia gravis).
• if you have heart problems, such as conduction disorders, slow heartbeats.
• if you have respiratory depression (difficulty breathing with slow and shallow breathing).
• if you are elderly or have a poor general state of health.
• if you have bleeding disorders or are being treated for them.

In addition, your doctor is aware that an injection of this medicine into inflamed tissue can cause an increased absorption of the active substance into the bloodstream and the effect of the active substance on your body may be reduced.

Your doctor will take into account that there is a greater risk of side effects on the nervous system if this medicine is administered in the head and neck region.

Children and adolescents

Lidocaine Aguettant 20 mg/ml should not be used in children and adolescents under 18 years of age.

Using Lidocaine Aguettant with other medicines

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines. Lidocaine Aguettant may affect other medicines or be affected by them.

In particular, tell your doctor if you are taking any of the following:

• medicines used to treat high blood pressure, such as diuretics;
• medicines used to treat heart problems, including irregular heartbeats, such as beta-blockers (e.g., metoprolol, propranolol) or calcium antagonists (e.g., amiodarone);
• medicines that constrict blood vessels (vasoconstrictors, e.g., epinephrine, norepinephrine);
• medicines used to relax muscles during general anesthesia (e.g., suxamethonium);
• sleeping pills and medicines that reduce the level of consciousness (sedatives);
• medicines that increase the risk of having epileptic seizures and convulsions (e.g., tramadol, bupropion);
• medicines that reduce the risk of having epileptic seizures and convulsions (e.g., diazepam);
• cimetidine, a medicine used to treat heartburn;
• antiviral medicines (e.g., ritonavir), macrolide antibiotics (e.g., erythromycin), or antifungal medicines (e.g., ketoconazole, itraconazole);
• ciprofloxacin (antibiotics);
• medicines used to treat epilepsy (phenobarbital, phenytoin, carbamazepine, or primidone);
• fluvoxamine, a medicine used in the treatment of mental illness;
• medicines used to reduce intraocular pressure (e.g., acetazolamide);
• other anesthetics, including local anesthetics.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine. Your doctor will then decide whether you should be given this medicine.

Pregnancy

Your doctor will only give you this medicine while you are pregnant if he considers it necessary. The dose should be as low as possible.

Breastfeeding

Lidocaine passes into human breast milk in small amounts. The use of lidocaine at the recommended doses is unlikely to affect the breastfed infant. Therefore, breastfeeding can continue during the use of lidocaine.

Driving and using machines

Lidocaine Aguettant may affect your ability to drive or use machines. Ask your doctor when it would be safe to drive or use machines.

Lidocaine Aguettant contains sodium

This medicine contains 23 mg of sodium (main component of table salt/kitchen salt) per syringe. This is equivalent to 1.2% of the maximum daily intake of 2 mg of sodium recommended by the WHO for an adult.

3. How to use Lidocaine Aguettant

Administration will be carried out by a healthcare professional with the appropriate training and experience.

Your doctor will decide what dose is appropriate for your individual case, based on your age and state of health, as well as the injection site, method used, and your response to the injection.

Use in children and adolescents

Lidocaine Aguettant 20 mg/ml should not be used in children and adolescents under 18 years of age.

Method of administration

Lidocaine Aguettant will be administered as an infiltration injection (intradermally, subcutaneously, or submucosally) in the areas surrounding the peripheral nerves.

If you use more Lidocaine Aguettant than you should

Since this medicine is administered by a healthcare professional with training, it is unlikely that you will be given too much Lidocaine Aguettant.

If you develop symptoms of overdose or not, it depends on the level of medicine present in your blood. The more lidocaine in your blood and the faster it is administered, the more likely you are to experience symptoms of an overdose with greater frequency and intensity.

A small overdose mainly affects your central nervous system. The adverse effects that occur will disappear in most cases after the administration of lidocaine is discontinued.

Regardless, if you think you have received too much of the medicine, or start to experience dizziness or fainting, numbness of the tongue, ringing in the ears, vomiting, or chills, you should inform the person who administered the injection immediately. The doctor will know how to control these symptoms and administer any necessary treatment.

If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Some side effects can be serious. Get medical help immediately if you experience an allergic reaction that causes:

• swelling of hands, feet, face, lips, mouth, tongue, or throat
• difficulty breathing
• itchy rash
• fever
• drop in blood pressure and shock.

These side effects are rare (may affect up to 1 in 1000 people).

Other side effects may include:

Very common (may affect more than 1 in 10 people)

• nausea.

Common (may affect up to 1 in 10 people)

• tingling, numbness, burning, pricking, or stabbing sensation (paresthesia)
• loss of consciousness
• pain or chills due to injections
• slow heartbeats
• low blood pressure or high blood pressure
• vomiting.

Rare (may affect up to 1 in 1000 people)

• changes in sensations or muscle weakness (neuropathy)
• seizures
• partial paralysis
• headache accompanied by a buzzing or crackling sound in the ears (tinnitus) and abnormal intolerance to light (photophobia)
• hearing loss (deafness)
• nerve damage
• drooping of the eyelids combined with constriction of the pupils and, occasionally, decreased sweating (Horner's syndrome). This occurs after application in the head/neck region.
• asymmetric sweating and flushing of the upper chest, neck, or face (harlequin syndrome)
• irregular heartbeats
• cardiac arrest
• double vision
• slow or interrupted breathing
• rash or hives.

Frequency not known (cannot be estimated from the available data)

• bluish discoloration of the skin, headaches, difficulty breathing, and fatigue due to abnormal amounts of methemoglobin (a form of hemoglobin that has a reduced ability to bind oxygen) in the blood (methemoglobinemia)

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if they are not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Lidocaine Aguettant

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the label, blister, and carton of the syringe. The expiry date is the last day of the month stated.

Store the pre-filled syringe in the closed blister until use. Do not freeze.

Once opened, the medicine should be used immediately.

Do not use this medicine if you notice visible signs of deterioration.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Contents of the pack and other information

Composition of Lidocaine Aguettant 20mg/ml solution for injection in pre-filled syringe

The active substance is lidocaine hydrochloride.

• Each ml of the solution for injection contains 20 mg of lidocaine hydrochloride (as lidocaine hydrochloride monohydrate).
• Each pre-filled syringe of 5 ml contains 100 mg of lidocaine hydrochloride (as lidocaine hydrochloride monohydrate).
• Each pre-filled syringe of 10 ml contains 200 mg of lidocaine hydrochloride (as lidocaine hydrochloride monohydrate).

The other ingredients are: sodium chloride, sodium hydroxide, concentrated hydrochloric acid (for pH adjustment), water for injections

Appearance and pack size

Lidocaine Aguettant 20 mg/ml solution for injection in pre-filled syringe is a clear, colorless solution for injection (injection). Lidocaine Aguettant is available in a 5 or 10 ml pre-filled syringe, packaged individually in a transparent blister. Carton of 1 or 10 pre-filled syringes. Not all pack sizes may be marketed.

Marketing authorization holder

Laboratoire Aguettant

1 rue Alexander Fleming

69007 Lyon

France

Manufacturer

Laboratoire Aguettant

1 rue Alexander Fleming

69007 Lyon

France

Laboratoire Aguettant

Lieu-Dit Chantecaille

07340 Champagne

France

Local representative:

Aguettant Ibérica S.L.

Parc Científic de Barcelona

Baldiri Reixac, 4-8 (Torre I)

08028 Barcelona

Date of last revision of this leaflet: 06/2024.

------------------------------------------------------------------------------------------------------------------------

This information is intended only for healthcare professionals:

Prepare the pre-filled syringe carefully as follows

The pre-filled syringe is for single patient use only. Discard the pre-filled syringe after use. Do not reuse it.

The contents of an unopened or undamaged pack are sterile and should not be opened until the moment of use.

The medicine should be inspected visually for particles or color changes before administration. The solution should only be used if it is clear, colorless, and free of particles or precipitates.

The medicine should not be used if the security seal of the syringe is broken.

The outer surface of the pre-filled syringe is sterile until the blister is opened.

When handled using an aseptic method, this medicine can be placed in a sterile area.

1. Connect the pre-filled syringe to the access device or needle. Slowly push the plunger to inject the required volume.